Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.

Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer. J Oncol Pract. 2018 09; 14(9):569-571.

View in: PubMed

subject areas

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Female
Humans
Lung Neoplasms
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Pemetrexed
Tomography, X-Ray Computed
Treatment Outcome

authors with profiles

Ravi Salgia